109 related articles for article (PubMed ID: 2211056)
21. [Computed tomographic studies on density kinetics after the bolus injection and infusion of perfluorooctylbromide (PFOB). Animal experimental studies].
Adam G; Günther RW; Prescher A; Goertz H; Schiffer C; Bruchmüller K; Limmer J
Rofo; 1992 May; 156(5):487-91. PubMed ID: 1596555
[TBL] [Abstract][Full Text] [Related]
22. Cyclooxygenase inhibition with ibuprofen: effect on biodistribution of perflubron emulsions in mice with mammary tumor.
Long DM; Vasquez F; Witt BL; Escobar JA; Long RA
Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):911-4. PubMed ID: 1391532
[TBL] [Abstract][Full Text] [Related]
23. Potential role of PFOB enhanced sonography of the kidney. I. Detection of renal function and acute tubular necrosis.
Munzing D; Mattrey RF; Reznik VM; Mitten RM; Peterson T
Kidney Int; 1991 Apr; 39(4):733-9. PubMed ID: 2051731
[TBL] [Abstract][Full Text] [Related]
24. AUR Memorial Award 1990. The physiologic basis of the radiodense renal medulla after the administration of blood pool contrast agent PFOB.
Coley BD; Mattrey RF; Mitten RM; Peterson T
Invest Radiol; 1990 Dec; 25(12):1287-93. PubMed ID: 2279907
[TBL] [Abstract][Full Text] [Related]
25. Perfluorocarbon emulsions prevent hypoxia of pancreatic β-cells.
Maillard E; Juszczak MT; Langlois A; Kleiss C; Sencier MC; Bietiger W; Sanchez-Dominguez M; Krafft MP; Johnson PR; Pinget M; Sigrist S
Cell Transplant; 2012; 21(4):657-69. PubMed ID: 21944582
[TBL] [Abstract][Full Text] [Related]
26. Dose response to aerosolized perflubron in a neonatal swine model of lung injury.
Kandler MA; von der Hardt K; Gericke N; Chada M; Dötsch J; Rascher W
Pediatr Res; 2004 Aug; 56(2):191-7. PubMed ID: 15181181
[TBL] [Abstract][Full Text] [Related]
27. Perfluoroctylbromide as a gastrointestinal contrast agent for MR imaging: use with and without glucagon.
Brown JJ; Duncan JR; Heiken JP; Balfe DM; Corr AP; Mirowitz SA; Eilenberg SS; Lee JK
Radiology; 1991 Nov; 181(2):455-60. PubMed ID: 1924788
[TBL] [Abstract][Full Text] [Related]
28. Development of highly fluid, concentrated and stable fluorocarbon emulsions for diagnosis and therapy.
Riess JG; Dalfors JL; Hanna GK; Klein DH; Krafft MP; Pelura TJ; Schutt EG
Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):839-42. PubMed ID: 1391519
[TBL] [Abstract][Full Text] [Related]
29. Experimental study of the relationship between perfluoro-octyl bromide emulsion and norepinephrine release in reperfusion arrhythmia: isolated guinea pig heart model.
Isaka M; Sakuma I; Shiiya N; Fukushima S; Nakai K; Kitabatake A; Yasuda K
Ann Thorac Cardiovasc Surg; 2008 Dec; 14(6):363-8. PubMed ID: 19131922
[TBL] [Abstract][Full Text] [Related]
30. Experimental comparison of EOE-13 and perfluoroctylbromide for the CT detection of hepatic metastases.
Patronas N; Miller DL; Girton M
Invest Radiol; 1984; 19(6):570-3. PubMed ID: 6096289
[TBL] [Abstract][Full Text] [Related]
31. Use of perfluorooctylbromide (PFOB) to detect liver abscesses with computed tomography. Safety and efficacy.
Mattrey RF; Brown JJ; Shelton RE; Ogino MT; Johnson KK; Mitten RM
Invest Radiol; 1991 Sep; 26(9):792-8. PubMed ID: 1938289
[TBL] [Abstract][Full Text] [Related]
32. Specific enhancement of intra-abdominal abscesses with perfluoroctylbromide for CT imaging.
Mattrey RF; Andrè M; Campbell J; Mitten R; Multer F; Hackney D; Long DM; Higgins CB
Invest Radiol; 1984; 19(5):438-46. PubMed ID: 6511250
[TBL] [Abstract][Full Text] [Related]
33. [Targeted combination and anti-inflammatory effects of anti-intercellular adhesion molecule 1 targeted perfluorooctylbromide particles on myocardial ischemia-reperfusion injury in rat model].
Shang Y; Tang H; Wei X; Hou J; Wang L; Li G; Song H; Fang H
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2013 Mar; 27(3):340-4. PubMed ID: 23672138
[TBL] [Abstract][Full Text] [Related]
34. Two-compartment radial diffusive exchange analysis of the NMR lineshape of (129)Xe dissolved in a perfluorooctyl bromide emulsion.
Gherase MR; Wallace JC; Cross AR; Santyr GE
J Chem Phys; 2006 Jul; 125(4):44906. PubMed ID: 16942191
[TBL] [Abstract][Full Text] [Related]
35. Prolonged shelf stability and biocompatibility of a concentrated injectable fluorocarbon emulsion.
Follana R; Klein D; Krafft MP; Long DM; Long CD; Ni Y; Riess JG; Valla A
Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):1059-61. PubMed ID: 1391426
[TBL] [Abstract][Full Text] [Related]
36. [Tumor imaging effects of perfluoroctylbromide (PFOB) emulsion].
Murata K; Itoh Y; Ayakawa Y; Miyata N
Nihon Gan Chiryo Gakkai Shi; 1988 Dec; 23(11):2669-78. PubMed ID: 3249107
[No Abstract] [Full Text] [Related]
37. Improvements in the ultrasonic contrast of targeted perfluorocarbon nanoparticles using an acoustic transmission line model.
Marsh JN; Hall CS; Scott MJ; Fuhrhop RW; Gaffney PJ; Wickline SA; Lanza GM
IEEE Trans Ultrason Ferroelectr Freq Control; 2002 Jan; 49(1):29-38. PubMed ID: 11833889
[TBL] [Abstract][Full Text] [Related]
38. Perfluoroctylbromide and hepatosplenic computed tomography. Preliminary clinical study.
Bruneton JN; Falewee MN; Balu-Maestro C; Normand F; Mattrey RF
Invest Radiol; 1988 Sep; 23 Suppl 1():S306-7. PubMed ID: 3198367
[TBL] [Abstract][Full Text] [Related]
39. Rayleigh theory of ultrasound scattering applied to liquid-filled contrast nanoparticles.
Flegg MB; Poole CM; Whittaker AK; Keen I; Langton CM
Phys Med Biol; 2010 Jun; 55(11):3061-76. PubMed ID: 20463372
[TBL] [Abstract][Full Text] [Related]
40. Molecular imaging with targeted perfluorocarbon nanoparticles: quantification of the concentration dependence of contrast enhancement for binding to sparse cellular epitopes.
Marsh JN; Partlow KC; Abendschein DR; Scott MJ; Lanza GM; Wickline SA
Ultrasound Med Biol; 2007 Jun; 33(6):950-8. PubMed ID: 17434667
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
